All Immunomedics articles
-
Business
Seattle Genetics cancels Immunomedics deal
Settlement also resolves disputes with shareholders
-
Business
$2bn Immunomedics–Seattle Genetics deal delayed amid shareholder infighting
Major investor venBio seeks to derail deal and replace board members